Comparative performance of the protocol of plasma rich in growth factors -universal 1 (PRGF-U1) for obtaining platelet rich plasma.
INTRODUCTION.
The concept of stimulation and maximization of healing mechanisms has gained prominence over the last years. In order to minimize the aftermath of invasive surgical treatments several methods have appeared. One of them is the platelet rich plasma (PRP) or plasma rich in growth factors (PRGF) that is a rich source of growth factors (GF).
1,2 PRP is a gel containing autologous human platelets concentrate (at concentrations higher than plasma levels) in a small volume of plasma. PRP is a source of easy access to GF, which are secreted by the platelets when the healing process begins, allowing the acceleration and improving the processes of healing and tissue regeneration.
1,2
The techniques for obtaining the PRP vary in the number of centrifugation steps the speed of centrifugation and the use of calcium chloride or other substances for their activation. 
1-3,6
Marx et al. claim that the PRP obtained with a single centrifugation does not produce a true therapeutic concentrate because the red cells interfere with the separation of the platelets. However, other authors do not recommend a two-step centrifugation because there is a risk of excessive manipulation, which leads to contamination or premature activation of platelets and loss of GF.
Currently there is a problem with the commercial kits because they include centrifuges already calibrated, having as main disadvantage their high cost, without the possibility of using other centrifuges. The aim of this study was to compare the platelet concentration obtained by using the plasma protocol rich in growth factors-universal 1 (PRGF-U1) and by the protocol of Anitua and Andia (PRP-A) for the production of platelet rich plasma.
MATERIALS AND METHODS.
This is a cross-sectional study carried out in the Unit of Second Specialization in Stomatology (USSS) and in the Laboratory of University Welfare of the Universidad Nacional de Trujillo (UNT). It was approved by the Committee of Permanent Bioethics Research of the Faculty of Medicine of the UNT. The sample consists of 16 patients who attended the Periodontics service of the USSS.
Selection criteria
Patients older than 18 years who had a good periodontal and general health status (evaluated by a resident of the USSS, previously calibrated by a periodontist, and through a health questionnaire) were included. Those who consumed medication, had blood parameters outside the normal range, pregnant women, and those who had any mental condition that made communication impossible were excluded. 6 For the PRGF-U1 a centrifugation of 1600rpm for 7 minutes was carried out at room temperature in a centrifuge with a rotor radius of 9.8cm (Heraeous Labofuge 200r, Daigger, USA). The PRP was extracted as follows: The topmost 0.5ml (PPP) were removed first, floowed by the middle 0.5ml (plasma under normal conditions), and finally 0.3ml were removed from the bottom of the tube (PRP), using an automatic micropipette.
Then 0.1ml of the PRP sample for each protocol were taken to a Newbauer Chamber and Thomas pipette to obtain the platelet concentration. Each micropipette step was performed by a single person calibrated for this purpose. The remaining PRP sample was processed for use in scheduled surgery.
Statistical analysis Data were processed in the SPSS 23.0 statistical package (IBM, SA). To compare platelet concentrates, t test was used with a significance level of p<0.05.
RESULTS.
The baseline platelet concentration was 371,250± 68,203 platelets/μL, for PRGF-U1 it was 747,875±121,645 platelets/μL and for PRP-A it was 595,000±129,202 platelets/μL.
A statistically significant difference (p<0.001) was found between both protocols. 
DISCUSSION.
The results of this research show that higher platelet concentrations are obtained with the PRGF-U1 protocol and these are in turn higher than those found by other authors, as shown in Table 1. 7-10 Thus, we believe that this new protocol could lead to clinical improvements since having a higher concentration of platelets should result in a greater clinical benefit.
Despite the limitations of the manual method used in this protocol, the previous calibration of the centrifuge and the use of a lower concentration of sodium citrate are factors that could improve the platelet concentration in PRP. Furthermore, any centrifuge may be employed during the protocol by using the mathematical formula to calculate rpm, without the need of using a commercial kit.
However, more studies are needed to compare this protocol with others, verifying the quality of the product and its effectiveness in laboratory and clinical settings.
CONCLUSION.
The PRGF-U1 protocol resulted in a higher platelet concentration compared to Anitúa and Andía protocol. 
